Stevanato Group S.p.A.
As of Oct 22, 2026, Stevanato Group S.p.A. is in Stage 2, the uptrend phase, now in week 12 (since Aug 5, 2026). It closed at $19.50, 29.1% below its 52-week high and above its 200-day average, which is falling.
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, No… More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 18 in Medical Instruments & Supplies · #1 of 272 in Health Care
Is STVN early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
STVN among Medical Instruments & Supplies33rd of 51 by relative strength
All 51 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | PLSE | Stage 2 · wk 34 | 98 | +1.3% |
| 2 | PDEX | Stage 2 · wk 36 | 97 | −13.3% |
| 3 | HBIO | Stage 2 · wk 11 | 95 | +3.6% |
| 4 | ATRC | Stage 2 · wk 10 | 89 | −1.1% |
| 5 | WST | Stage 2 · wk 24 | 82 | +4.8% |
| 6 | BDX | Stage 2 · wk 11 | 81 | +9.8% |
| 7 | ICUI | Stage 3 · wk 1 | 81 | +3.1% |
| 8 | OSUR | Stage 3 · wk 8 | 75 | −4.8% |
| …33 | STVN | Stage 2 · wk 12 | 36 | −10.1% |
Stevanato Group S.p.A.: quick answers
What stage is Stevanato Group S.p.A. in?
As of Oct 22, 2026, Stevanato Group S.p.A. (STVN) is in Stage 2, the uptrend phase. It entered Stage 2 on Aug 5, 2026 and is in week 12. What the four stages mean
Is Stevanato Group S.p.A. in an uptrend?
Yes. Stevanato Group S.p.A. is in a Stage 2 uptrend. It trades 7.7% above its 200-day average, which is falling.
How far is Stevanato Group S.p.A. from its 52-week high?
Stevanato Group S.p.A. closed at $19.50 on Oct 22, 2026, 29.1% below its 52-week high of $27.51. Its 52-week low is $13.38.
How has Stevanato Group S.p.A. performed over the past year?
As of Oct 22, 2026, Stevanato Group S.p.A. is down 25.7% over the past year and down 4.9% so far in 2026.
Which sector and industry is Stevanato Group S.p.A. in?
Stevanato Group S.p.A. is in the Medical Instruments & Supplies industry, part of the Health Care sector.
About this companyHealth Care· Medical Instruments & Supplies
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.